Table 1.
Patient characteristics (n=59).
| Median Age (range) | 11 (1.6-24) |
| Male / Female | 36 / 23 |
| Disease | |
| ALL | 23 |
| AML | 19 |
| CML/JMML | 10 |
| MDS | 5 |
| Other | 2 |
| Disease Status | |
| CR1 | 18 |
| CR2/CR3 | 20 |
| Stable/First chronic phase | 12 |
| Relapse/Refractory | 9 |
| Donor | |
| Median age (range) | 35 (19-55) |
| Male / Female | 31 / 28 |
| Graft | |
| T-cell deplete | 40 |
| Unmanipulated | 19 |
| Median cell dose (range) | |
| TNC (108/kg) | 2.03 (0.02-8.5) |
| CD34+ cell (106/kg) | 5.12 (0.18-23.9) |
| CD3+ cell (106/kg) | |
| T-cell deplete | 1.52 (0.37-7.7) |
| Unmanipulated | 49.4 (19.1-100) |